We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.39B
AUM Growth
+$62.3M
Cap. Flow
-$30.3M
Cap. Flow %
-2.17%
Top 10 Hldgs %
32.32%
Holding
406
New
134
Increased
46
Reduced
56
Closed
155

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$229M
2
PYPL icon
PayPal
PYPL
+$15.3M
3
FDX icon
FedEx
FDX
+$12.7M
4
JWN
Nordstrom
JWN
+$12.1M
5
MU icon
Micron Technology
MU
+$12M

Top Sells

Rank Stock Value
1
SPCE icon
Virgin Galactic
SPCE
+$37.5M
2
KNX icon
Knight Transportation
KNX
+$15.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$14.5M
4
EGHT icon
8x8 Inc
EGHT
+$13.8M
5
BJ icon
BJs Wholesale Club
BJ
+$13.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.79%
2 Industrials 8.58%
3 Healthcare 7.87%
4 Technology 6.57%
5 Consumer Staples 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FREE
201
CALL
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$764K 0.05%
763,900
-26,100
-3% -$260K
XLY icon
202
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.8B
$754K 0.05%
+12,018
New +$731K
TBCH
203
CALL
Turtle Beach Corp
TBCH
$252M
$710K 0.05%
+75,000
New +$736K
XLB icon
204
State Street Materials Select Sector SPDR ETF
XLB
$8.69B
$697K 0.05%
+22,710
New +$671K
EIGR
205
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$677K 0.05%
+1,516
New +$538K
PRVB
206
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$651K 0.05%
+43,660
New +$389K
KPTI icon
207
Karyopharm Therapeutics
KPTI
$154M
$643K 0.05%
2,236
-18,403
-89% -$3.99M
UTZ icon
208
CALL
Utz Brands
UTZ
$1.25B
$639K 0.05%
466,666
– –
SLNO
209
DELISTED
Soleno Therapeutics
SLNO
$612K 0.04%
+13,888
New +$355K
WSM icon
210
Williams-Sonoma
WSM
$27.3B
$610K 0.04%
16,614
-132,562
-89% -$4.6M
ADNT icon
211
Adient
ADNT
$1.69B
$572K 0.04%
+26,903
New +$597K
FOMX
212
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$562K 0.04%
+168,778
New +$537K
XAIR icon
213
Beyond Air
XAIR
$3.91M
$559K 0.04%
267
-108
-29% -$187K
GPN icon
214
Global Payments
GPN
$23.8B
$536K 0.04%
2,937
-18,751
-86% -$3.22M
SKIL icon
215
CALL
Skillsoft
SKIL
$63.9M
$531K 0.04%
19,047
-2,620
-12% -$536K
ARVN icon
216
Arvinas
ARVN
$526M
$512K 0.04%
+12,452
New +$365K
BDSI
217
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$493K 0.04%
77,957
-422,065
-84% -$2.48M
GE icon
218
GE Aerospace
GE
$369B
$490K 0.04%
8,803
+2,045
+30% +$106K
XME icon
219
State Street SPDR S&P Metals & Mining ETF
XME
$3.76B
$488K 0.04%
+16,668
New +$455K
IMTX icon
220
CALL
Immatics
IMTX
$1.17B
$486K 0.03%
250,000
– –
TXMD icon
221
CALL
TherapeuticsMD
TXMD
$23.6M
$484K 0.03%
4,000
-8,000
-67% -$1.15M
LTHM
222
DELISTED
Livent Corporation
LTHM
$432K 0.03%
+50,503
New +$386K
TXN icon
223
Texas Instruments
TXN
$247B
$403K 0.03%
+3,139
New +$387K
PRTK
224
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$403K 0.03%
100,000
-58,650
-37% -$203K
FISV
225
Fiserv Inc
FISV
$29.5B
$400K 0.03%
3,460
-6,118
-64% -$675K
7 8
9
10 11

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q4 2019 Portfolio in Review

As of Q4 2019, J. Goldman & Co held 406 positions worth $1.39B, up 4.7% from $1.33B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

J. Goldman & Co's Q4 2019 filing shows 134 new, 46 increased, 56 reduced and 155 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 741,000 shares worth $240M. The largest sale was Virgin Galactic, an estimated $37.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • J. Goldman & Co's largest Q4 2019 buy was iShares Core S&P 500 ETF: 741,000 shares worth $240M.
  • J. Goldman & Co added most to FedEx in Q4 2019, an estimated $12.7M increase.
  • J. Goldman & Co's biggest Q4 2019 reduction was Jack in the Box, cutting an estimated $10.6M.
  • J. Goldman & Co fully exited Virgin Galactic in Q4 2019, selling an estimated $37.5M.
  • J. Goldman & Co's ten largest holdings make up 32% of its $1.39B portfolio in Q4 2019.
  • J. Goldman & Co opened 134 new positions and closed 155 in Q4 2019.
  • J. Goldman & Co's portfolio value rose 4.7% quarter-over-quarter to $1.39B.

Based on J. Goldman & Co's 13F filing for Q4 2019, filed 14 Feb 2020.